Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-7R Gene Polymorphism and Vedolizumab Response in Ulcerative Colitis
NCT07398586Phase 4Completed
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Jan 2020
- Primary completion
- Dec 2024
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of vedolizumab in ulcerative colitis (UC), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Started Jan 2020; status: completed.
02
Drugs
vedolizumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07398586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07398586.